The paired availability design for historical controls

BMC Medical Research Methodology

Volumn 1, Issue , 2001, Pages 1-7

  Baker, Stuart G ^a   Lindeman, Karen S ^b   Kramer, Barnett S ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; HOSPITAL; MEDICAL RESEARCH; METHODOLOGY; PAIRED AVAILABILITY DESIGN; RANDOMIZATION; STATISTICAL ANALYSIS;

EID: 2142837750     PISSN: 14712288     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2288-1-9     Document Type: Article

References (20)

1. Concato J, Feinstein AR, Holford TR: The risk of determining risk with multivariable models. Ann Intern Med 1993, 118:201-210
2. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997, 27:757-763
3. Concato J, Shah H, Horwitz RI: Randomized controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000, 342:1887-92
4. Benson K, Hartz AJ: A comparison of observational and randomized, controlled trials. N Engl J Med 2000, 342:1878-86
5. Baker SG, Lindeman KS: Randomized and nonrandomized studies. Statistical considerations. Anesthesiology 2000, 92:928-930
6. Egger M, Schneider M, Smith GD: Spurious precision? Meta-analysis of observational studies. Br Med J 1998, 316:140-144
7. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S: The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trials data. Ann Intern Med 1995, 123:860-872
8. Grady D, Hulley SB: Hormones to prevent coronary disease in women: when are observational studies adequate evidence? Ann Intern Med 2000, 133:999-1001
9. Baker SG, Lindeman KS: Rethinking historical controls. Biostatistics, 2001
10. Smith RP, Meier P: Observational studies and randomized trials. New Engl J Med 2000, 343:1196
11. Sandler RS: Aspirin and other nonsteroidal anti-inflamatory agents in the prevention of colorectal cancer. PPO Updates 1997, 11:1-14
12. Baker SG, Kramer BS: Good for women, good for men, bad for people: Simpson's paradox and the importance of sex-specific analysis in observational studies. Journal of Women's Health & Gender-Based Medicine, 2001
13. Baker SG, Lindeman KS: The paired availability design: A proposal for evaluating epidural analgesia during labor. Statistics in Medicine 1994, 13:2269-2278
14. Baker SG: The paired availability design: an update. In Abel U, Koch A, Nonrandomized Comparative Clinical Studies, Dusseldorf: Medinform-Verlag; 199879-84
15. Pocock SJ: Clinical trials. A practical approach. Chichester: John Wiley and Sons, 1982
16. Sheiner LB, Rubin DB: Intention-to-treat analysis and the goals of clinical-trials. Clin Pharmacol Ther 1995, 57:6-15
17. Angrist JD, Imbens GW, Rubin DR: Identification of causal effects using instrumental variables. Journal of the American Statistical Association 1996, 92:444-455
18. Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985, 312:1604-8
19. DerSimonian R, Laird N: Meta-analysis in clinical trials. Controlled Clinical Trials 1986, 7:177-188
20. Follman DA, Proschan MA: Inference in random effects meta-analysis. Biometrics 1999, 55:732-737